{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:27:32Z","timestamp":1753889252789},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.3816\/clm.2008.n.045","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T02:53:18Z","timestamp":1224039198000},"page":"312-314","source":"Crossref","is-referenced-by-count":6,"title":["Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature"],"prefix":"10.3816","volume":"8","author":[{"given":"Carlos Fern\u00e1ndez","family":"de Larrea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Cibeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Vallansot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Blad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.045_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukaemia","volume":"13","author":"Blad\u00e9","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2008.n.045_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukaemia: an evaluation of response to therapy","volume":"83","author":"Noel","year":"1987","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2008.n.045_bib3","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy and cytogenetic characteristics","volume":"93","author":"Garcia-Sanz","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.045_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.20272","article-title":"Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature","volume":"78","author":"Saccaro","year":"2005","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.n.045_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.045_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11864-001-0034-4","article-title":"Plasma cell leukemia","volume":"2","author":"Hayman","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"10.3816\/CLM.2008.n.045_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000203599","article-title":"Increased serum CA125 levels in plasma cell dyscrasias","volume":"98","author":"Iwasaki","year":"1997","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2008.n.045_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.2003.04353.x","article-title":"Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias","volume":"121","author":"Luminari","year":"2003","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.045_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.153.5.2102","article-title":"Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient","volume":"153","author":"Takahashi","year":"1994","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2008.n.045_bib10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1172\/JCI111875","article-title":"Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients","volume":"75","author":"Hayes","year":"1985","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2008.n.045_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01806502","article-title":"Value of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in diseasefree follow-up patients and sensitivity in patients at diagnosis of the first metastasis","volume":"37","author":"Vizcarra","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CLM.2008.n.045_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0046-8177(86)80046-6","article-title":"Epithelial membrane antigen in hematopoietic neoplasms","volume":"17","author":"Al Saati","year":"1986","journal-title":"Hum Pathol"},{"key":"10.3816\/CLM.2008.n.045_bib13","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood.V96.9.3147","article-title":"Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma","volume":"96","author":"Treon","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.045_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1984.254","article-title":"Ovarian cancer antigen CA125: a prospective clinical assessment of its role as tumour marker","volume":"50","author":"Canney","year":"1984","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2008.n.045_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/10428190600580882","article-title":"CA125 expression in patients with non-Hodgkin's lymphoma","volume":"47","author":"Wei","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.n.045_bib16","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1080\/1042819031000104079","article-title":"Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma","volume":"44","author":"Bairey","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.n.045_bib17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/10428190500204781","article-title":"Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients","volume":"46","author":"Batlle","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.n.045_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<576::AID-CNCR21>3.3.CO;2-7","article-title":"Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity","volume":"82","author":"Lazzarino","year":"1998","journal-title":"Cancer"},{"key":"10.3816\/CLM.2008.n.045_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2257.2004.00655.x","article-title":"CA125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies","volume":"27","author":"Dilek","year":"2005","journal-title":"Clin Lab Haematol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T12:08:25Z","timestamp":1684584505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1557919011702542"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.045","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}